Correlation Between Aerovate Therapeutics and Glucose Health

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Glucose Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Glucose Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Glucose Health, you can compare the effects of market volatilities on Aerovate Therapeutics and Glucose Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Glucose Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Glucose Health.

Diversification Opportunities for Aerovate Therapeutics and Glucose Health

-0.53

Correlation Coefficient

Aerovate Therapeutics  Glucose Health

Excellent diversification

The 3 months correlation between Aerovate and Glucose is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Glucose Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Glucose Health and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Glucose Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Glucose Health has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Glucose Health go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Glucose Health

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 12.08 times less return on investment than Glucose Health. But when comparing it to its historical volatility, Aerovate Therapeutics is 6.29 times less risky than Glucose Health. It trades about 0.06 of its potential returns per unit of risk. Glucose Health is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  12.00  in Glucose Health on October 21, 2024 and sell it today you would earn a total of  2.00  from holding Glucose Health or generate 16.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  Glucose Health

Aerovate Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Glucose Health

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Glucose Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather weak basic indicators, Glucose Health may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Aerovate Therapeutics and Glucose Health

The main advantage of trading using opposite Aerovate Therapeutics and Glucose Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Glucose Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Glucose Health will offset losses from the drop in Glucose Health's long position.

The idea behind Aerovate Therapeutics and Glucose Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.